These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166 [TBL] [Abstract][Full Text] [Related]
24. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients. Lepore JJ; Dec GW; Zapol WM; Bloch KD; Semigran MJ J Heart Lung Transplant; 2005 Nov; 24(11):1950-6. PubMed ID: 16297803 [TBL] [Abstract][Full Text] [Related]
25. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Salzberg SP; Lachat ML; von Harbou K; Zünd G; Turina MI Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674 [TBL] [Abstract][Full Text] [Related]
26. [The hemodynamics of the lesser circulation before and after heart transplantation in patients with dilated cardiomyopathy]. Shumakov VI; Kormer AIa; Kozakov EN; Chestukhin VV; Shemakin SIu Grud Serdechnososudistaia Khir; 1993; (6):4-7. PubMed ID: 8312006 [TBL] [Abstract][Full Text] [Related]
27. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688 [TBL] [Abstract][Full Text] [Related]
28. Managing pulmonary hypertension in heart transplantation: meeting the challenge. Coe PF Crit Care Nurse; 2000 Apr; 20(2):22-8; quiz 29-30. PubMed ID: 11873750 [TBL] [Abstract][Full Text] [Related]
29. Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year. Chau EM; Bailey KR; Mahoney DW; Frantz RP; McGregor CG; Daly RC; Edwards BS; Olson LJ; Rodeheffer RJ Circulation; 1996 Nov; 94(9 Suppl):II267-72. PubMed ID: 8901758 [TBL] [Abstract][Full Text] [Related]
30. Pre-existing elevated pulmonary vascular resistance: long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation. Tenderich G; Koerner MM; Stuettgen B; Mirow N; Arusoglu L; Morshuis M; Bairaktaris A; Minami K; Koerfer R J Cardiovasc Surg (Torino); 2000 Apr; 41(2):215-9. PubMed ID: 10901524 [TBL] [Abstract][Full Text] [Related]
31. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation. Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754 [TBL] [Abstract][Full Text] [Related]
32. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849 [TBL] [Abstract][Full Text] [Related]
33. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967 [TBL] [Abstract][Full Text] [Related]
34. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. Michaels AD; Chatterjee K; De Marco T J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633 [TBL] [Abstract][Full Text] [Related]
35. [Precapillary pulmonary hypertension: effect of Captopril]. Sanguinetti M; Galiè N; Magelli C; Orselli L; Magnani B G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221 [TBL] [Abstract][Full Text] [Related]
36. Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation. Gómez-Moreno S; Lage E; Hernández A; Campos A; Cabezón S; Ordóñez A; Hinojosa R Transplant Proc; 2005 Apr; 37(3):1550-1. PubMed ID: 15866670 [TBL] [Abstract][Full Text] [Related]
37. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant. Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617 [TBL] [Abstract][Full Text] [Related]
38. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure. Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999 [TBL] [Abstract][Full Text] [Related]
39. Inhaled nitric oxide in the preoperative evaluation of pulmonary hypertension in heart transplant candidates. Mahajan A; Shabanie A; Varshney SM; Marijic J; Sopher MJ J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):51-6. PubMed ID: 17289480 [TBL] [Abstract][Full Text] [Related]
40. Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation. Duszańska A; Wasilewski J; Gierlotka M; Zakliczyński M Adv Med Sci; 2020 Sep; 65(2):298-303. PubMed ID: 32454454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]